Transdermal patch is a drug delivery device in which the drugs are incorporated and is design in such a way that it releases the drug in sustained and at predetermined rate to deliver the drug through the skin to the systemic circulation painlessly. The aim of this research study was to formulate a controlled and sustained release transdermal matrix type patch of Methimazole. The matrix patch was prepared by solvent casting method using a various polymer in different concentration, HPMC (hydrophilic), Eudragit RL100 and Ethyl cellulose (hydrophobic) polymer. Total 9 prototype formulation were prepared and it was subjected for various evaluation test; weight uniformity, Folding endurance, thickness, Drug content, percent moisture content, percent Moisture uptake and In-vitro drug release study using Franz diffusion cell. The in-vitro CDR% data was fit into kinetics model to see the release kinetics from the patches. The Formulation F5 was choosen as a best formulation according to in-vitro drug release study. The in-vitro release was found 81.12 % in 12 hours, it followed zero order kinetics. The nature of polymer and concentration ratio of polymers plays a crucial role for obtaining a good transdermal patch design; therefore optimisation is very important step to formulate a desired TDDS. Therefore the result of the study encourages a further study and is hopeful that the present study would contribute to the recent pharmaceutical research for formulation development.
Cite this article:
Nani Tadhi, Himansu Chopra, Gyanendra Kumar Sharma. Formulation and Evaluation of Transdermal patch of Methimazole. Research Journal of Pharmacy and Technology. 2021; 14(9):4667-2. doi: 10.52711/0974-360X.2021.00811
Nani Tadhi, Himansu Chopra, Gyanendra Kumar Sharma. Formulation and Evaluation of Transdermal patch of Methimazole. Research Journal of Pharmacy and Technology. 2021; 14(9):4667-2. doi: 10.52711/0974-360X.2021.00811 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-9-25
1. Shinde Utkarsh P., Pagar Hemant B., Barhate Shashikant D., Patil Yogesh K., Roundal Mahendra J., Suryavanshi Ravikiran N., Agrawal Yogesh S., Patel Akash K. Recent Advances in Transdermal Drug Delivery System. Journal of Pharmacy Research. 2012, 5(1), 447-456.
2. Dhananjay M. Patil, Abdullah S. Farooque, Vinod A. Bairagi Formulation. Development and Evaluation of Sustained Release Matrix Tablet of Methimazole. Indo American Journal of Pharmaceutical Sciences. http://doi.org/10.5281/zenodo.1145732
3. Pradum Pundlikrao Ige, Dipak Ramdas Mahajan and Raju Onkar Sonawane. Development of Mucoadhesive Sustained Release Matrix Tablets of Methimazole for oral Delivery. Indian Journal of Pharmaceutical Education and Research. 2015; 49(4).
4. Xi Wu Xi Wu, Hong Liu, Xixing Zhu, Jun Shen, Yongquan Shi, Zhimin Liu, Mingjun Gu, Zhimin Song. Efficacy and safety of methimazole ointment for patients with hyperthyroidism. Environmental Toxicology and Pharmacology. 36(2013) 1109–1112, http://dx.doi.org/10.1016/j.etap.2013.09.015
5. Adam C. Watkinson, Mary-Carmel Kearney, Helen L. Quinn, Aaron J Courtenay and Ryan F. Donnelly (2015): Future of the transdermal drug delivery market – have we barely touched the surface?, Expert Opinion on Drug Delivery, DOI:10.1517/17425247.2016.1130034
6. AVS Madhu Latha, T Naga Ravikiran, J N Suresh Kumar. Formulation, optimization and Evaluation of Glibenclamide Transdermal Patches by Using chitosan Polymer. Asian J. Pharm. Tech. 2019; 9(1):01-07. Doi: 10.5958/2231-5713.2019.00001.1
7. Sachin B. Jadhav, Ankita R. Koshti, M.M Bari, S.D. Barhate. Formulation optimization and Evaluation of Transdermal Patch of Losartan Potassium containing DMSO as permeation enhancer. Asian J. Pharm Tech 2019; 9(3): 220-227. DOI: 10.5958/2231-5713.2019.00037.0
8. Beny Baby, Abin Abraham and S Jayaprakas. Design and Evaluation of Transdermal Patches of Propanolol Hydrochloride. Research J. Pharm. and Tech. 2(1): Jan.-Mar. 2009; Page 195-200
9. Ismail Hussain, Ravikumar, Narayanaswamy VB, Injamamul Haque, Mohibul Hoque. Design and Evaluation of Transdermal Paches containing Risperidone. Asian J. Res. Pharm. Sci. 2016 (4): 208-222.doi: 10.5958/2231-5659.2016.00030.8
10. S. S. Solanki, K. B. Patel, J. G. Patel, M. P. Patel, J. K. Patel. Development of Matrix Type Transdermal Patches of Granisetron Hydrochloride: Physicochemical and in-Vitro Characterization. Research J. Pharm. and Tech. 5(7): July 2012; Page 973-977
11. G. Vasavi, P. Naga Haritha, B. Chandrashekar. Formulation Development and Invitro Evaluation of Transdermal Patches of Tramadol Hcl. Asian J. Res. Pharm. Sci. 2018; 8(3):123-129. doi: 10.5958/2231-5659.2018.00021.8
12. Chakraborty Prithviraj, Dey Biplab K., Bahadur Sanjib, Thakkar Suresh and Das Sudip. Design, Development, Physicochemical and In Vitro Evaluation of Transdermal Patches Containing Verapamil Hydrochloride in Ethyl Cellulose - Povidone Matrices. Research J. Pharm. and Tech. 2(1): Jan.-Mar. 2009; Page 168-172,
13. Suresh V Kulkarni, Ranjit Kumar P., Nikunj Patel, Ramesh B., Someshwara Rao B. and Ashok Kumar P. Development and Evaluation of Diltiazem Hydrochloride Transdermal Patches by Using Glycerol and Castor Oil as Plasticizers. Research J. Pharm. and Tech. 3 (3): July-Sept. 2010; Page 905-909
14. Suja C., Ramasamy C. and Narayanacharyulu R. Development and Evaluation of Lisinopril Transdermal Patches. Research J. Pharm. and Tech. 4(8): August 2011; Page 1260-1264
15. Vijay Singh Jatav, Jitendra Singh Saggu, Ashish Kumar Sharma, Shantosh Kumar Singh. Effect of Dimethyl Sulphoxides as Permeation Enhancer on Transdermal Patch of Nebivolol Hydrochloride. Asian J. Res. Pharm. Sci. 3(1): Jan-Mar.2013; page 08-11